ALT: alanine transaminase; AST: aspartate transaminase; DAO: diamine
oxidase; DBIL: direct bilirubin; FAP: fat attenuation parameter; GGT:
gamma-glutamyl transpeptidase; HDL: high-density lipoprotein; HOMA-IR:
homeostasis model assessment of insulin resistance; IBIL: indirect
bilirubin; LDL: low-density lipoprotein; LPS: lipopolysaccharide; LSM:
liver stiffness measurement; NAFLD: nonalcoholic fatty liver disease;
TBIL: total bilirubin; TC: total cholesterol; TG: triglyceride.
Significant P values are indicated in bold font.
Table 4: Effects of metabolic therapy in NAFLD patients with
normal or elevated intestinal permeability